Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity

Lessons from Melanoma and Vitiligo

Uchi Hiroshi, Rodica Stan, Mary Jo Turk, Manuel E. Engelhorn, Gabrielle A. Rizzuto, Stacie M. Goldberg, Jedd D. Wolchok, Alan N. Houghton

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

A relationship between melanoma and vitiligo, a skin disorder characterized by the loss of melanocytes, has been postulated for many decades. In some cases, vitiligo is almost certainly a manifestation of autoimmune-mediated destruction of melanocytes. Melanocytes and melanoma cells share melanocyte differentiation antigens. Based on a number of observations, de novo vitiligo developing in patients with melanoma has been regarded as a sign of good prognosis. The immune system tolerates or ignores differentiation antigens because these antigens are self-derived. Therefore, immune tolerance or ignorance must be overcome to prime naïve T and B cells to induce cancer immunity and autoimmunity against melanocyte differentiation antigens. Mouse models of concurrent melanoma and autoimmune vitiligo have revealed strategies to overcome immune ignorance or tolerance to melanocyte differentiation antigens: immunization with self-antigens as altered self (e.g., orthologues or mutated versions), expression in viral vectors, passive immunization with antibodies or T cells, incorporating potent adjuvants into active immunization, and blockade or removal of a downregulatory mechanism. Extensive investigations into the mechanisms that lead to tumor immunity and autoimmunity elicited by certain differentiation antigens have further revealed a variety of distinct cellular and molecular requirements, which are redundant and alternative.

Original languageEnglish
Pages (from-to)215-241
Number of pages27
JournalAdvances in Immunology
Volume90
DOIs
Publication statusPublished - May 29 2006

Fingerprint

Vitiligo
Melanocytes
Autoimmunity
Differentiation Antigens
Immunity
Melanoma
Neoplasms
T-Lymphocytes
Immune Tolerance
Passive Immunization
Autoantigens
Immune System
Immunization
Vaccination
B-Lymphocytes
Antigens
Skin
Antibodies

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Hiroshi, U., Stan, R., Turk, M. J., Engelhorn, M. E., Rizzuto, G. A., Goldberg, S. M., ... Houghton, A. N. (2006). Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity: Lessons from Melanoma and Vitiligo. Advances in Immunology, 90, 215-241. https://doi.org/10.1016/S0065-2776(06)90006-6

Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity : Lessons from Melanoma and Vitiligo. / Hiroshi, Uchi; Stan, Rodica; Turk, Mary Jo; Engelhorn, Manuel E.; Rizzuto, Gabrielle A.; Goldberg, Stacie M.; Wolchok, Jedd D.; Houghton, Alan N.

In: Advances in Immunology, Vol. 90, 29.05.2006, p. 215-241.

Research output: Contribution to journalReview article

Hiroshi, U, Stan, R, Turk, MJ, Engelhorn, ME, Rizzuto, GA, Goldberg, SM, Wolchok, JD & Houghton, AN 2006, 'Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity: Lessons from Melanoma and Vitiligo', Advances in Immunology, vol. 90, pp. 215-241. https://doi.org/10.1016/S0065-2776(06)90006-6
Hiroshi, Uchi ; Stan, Rodica ; Turk, Mary Jo ; Engelhorn, Manuel E. ; Rizzuto, Gabrielle A. ; Goldberg, Stacie M. ; Wolchok, Jedd D. ; Houghton, Alan N. / Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity : Lessons from Melanoma and Vitiligo. In: Advances in Immunology. 2006 ; Vol. 90. pp. 215-241.
@article{46cb20e450574b0ba57250bb1a89cada,
title = "Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity: Lessons from Melanoma and Vitiligo",
abstract = "A relationship between melanoma and vitiligo, a skin disorder characterized by the loss of melanocytes, has been postulated for many decades. In some cases, vitiligo is almost certainly a manifestation of autoimmune-mediated destruction of melanocytes. Melanocytes and melanoma cells share melanocyte differentiation antigens. Based on a number of observations, de novo vitiligo developing in patients with melanoma has been regarded as a sign of good prognosis. The immune system tolerates or ignores differentiation antigens because these antigens are self-derived. Therefore, immune tolerance or ignorance must be overcome to prime na{\"i}ve T and B cells to induce cancer immunity and autoimmunity against melanocyte differentiation antigens. Mouse models of concurrent melanoma and autoimmune vitiligo have revealed strategies to overcome immune ignorance or tolerance to melanocyte differentiation antigens: immunization with self-antigens as altered self (e.g., orthologues or mutated versions), expression in viral vectors, passive immunization with antibodies or T cells, incorporating potent adjuvants into active immunization, and blockade or removal of a downregulatory mechanism. Extensive investigations into the mechanisms that lead to tumor immunity and autoimmunity elicited by certain differentiation antigens have further revealed a variety of distinct cellular and molecular requirements, which are redundant and alternative.",
author = "Uchi Hiroshi and Rodica Stan and Turk, {Mary Jo} and Engelhorn, {Manuel E.} and Rizzuto, {Gabrielle A.} and Goldberg, {Stacie M.} and Wolchok, {Jedd D.} and Houghton, {Alan N.}",
year = "2006",
month = "5",
day = "29",
doi = "10.1016/S0065-2776(06)90006-6",
language = "English",
volume = "90",
pages = "215--241",
journal = "Advances in Immunology",
issn = "0065-2776",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity

T2 - Lessons from Melanoma and Vitiligo

AU - Hiroshi, Uchi

AU - Stan, Rodica

AU - Turk, Mary Jo

AU - Engelhorn, Manuel E.

AU - Rizzuto, Gabrielle A.

AU - Goldberg, Stacie M.

AU - Wolchok, Jedd D.

AU - Houghton, Alan N.

PY - 2006/5/29

Y1 - 2006/5/29

N2 - A relationship between melanoma and vitiligo, a skin disorder characterized by the loss of melanocytes, has been postulated for many decades. In some cases, vitiligo is almost certainly a manifestation of autoimmune-mediated destruction of melanocytes. Melanocytes and melanoma cells share melanocyte differentiation antigens. Based on a number of observations, de novo vitiligo developing in patients with melanoma has been regarded as a sign of good prognosis. The immune system tolerates or ignores differentiation antigens because these antigens are self-derived. Therefore, immune tolerance or ignorance must be overcome to prime naïve T and B cells to induce cancer immunity and autoimmunity against melanocyte differentiation antigens. Mouse models of concurrent melanoma and autoimmune vitiligo have revealed strategies to overcome immune ignorance or tolerance to melanocyte differentiation antigens: immunization with self-antigens as altered self (e.g., orthologues or mutated versions), expression in viral vectors, passive immunization with antibodies or T cells, incorporating potent adjuvants into active immunization, and blockade or removal of a downregulatory mechanism. Extensive investigations into the mechanisms that lead to tumor immunity and autoimmunity elicited by certain differentiation antigens have further revealed a variety of distinct cellular and molecular requirements, which are redundant and alternative.

AB - A relationship between melanoma and vitiligo, a skin disorder characterized by the loss of melanocytes, has been postulated for many decades. In some cases, vitiligo is almost certainly a manifestation of autoimmune-mediated destruction of melanocytes. Melanocytes and melanoma cells share melanocyte differentiation antigens. Based on a number of observations, de novo vitiligo developing in patients with melanoma has been regarded as a sign of good prognosis. The immune system tolerates or ignores differentiation antigens because these antigens are self-derived. Therefore, immune tolerance or ignorance must be overcome to prime naïve T and B cells to induce cancer immunity and autoimmunity against melanocyte differentiation antigens. Mouse models of concurrent melanoma and autoimmune vitiligo have revealed strategies to overcome immune ignorance or tolerance to melanocyte differentiation antigens: immunization with self-antigens as altered self (e.g., orthologues or mutated versions), expression in viral vectors, passive immunization with antibodies or T cells, incorporating potent adjuvants into active immunization, and blockade or removal of a downregulatory mechanism. Extensive investigations into the mechanisms that lead to tumor immunity and autoimmunity elicited by certain differentiation antigens have further revealed a variety of distinct cellular and molecular requirements, which are redundant and alternative.

UR - http://www.scopus.com/inward/record.url?scp=33646781575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646781575&partnerID=8YFLogxK

U2 - 10.1016/S0065-2776(06)90006-6

DO - 10.1016/S0065-2776(06)90006-6

M3 - Review article

VL - 90

SP - 215

EP - 241

JO - Advances in Immunology

JF - Advances in Immunology

SN - 0065-2776

ER -